Wall Street is drawing fresh lines across the large-cap biopharma landscape. Jefferies initiated coverage on Gilead Sciences Inc. (NASDAQ:GILD) with a Buy rating and a $180 price target, while ...

Coherus Oncology (NASDAQ:CHRS) outlined progress on its transition to an “innovative oncology” company during its ...

Prostate cancer often has no symptoms early on, but you may later have frequent urination, or blood in your urine or semen. Although less common, you may have painful ejaculation with prostate cancer.

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Enter household income you received, such as wages, unemployment, interest and dividends. Choose the filing status you use when you file your tax return Input the total of your itemized deductions, ...

Check the currency rates against all the world currencies here. The currency converter below is easy to use and the currency rates are updated frequently. This is very much needed given the extreme ...

Explore healthcare trends, quizzes, tips, web stories, and medical humor in our weekly newsletter, Volume No.4, Issue No.10 ...

PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the 'Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported ...

Vir Biotechnology Inc (VIR) reports reduced expenses and a promising collaboration with Estelas, setting the stage for future growth.

Good afternoon, everyone, and welcome to the Caris Life Sciences Q4 2025 Earnings Call. My name is Dana, and I will be your coordinator today. Thank you. Earlier today, Caris Life Sciences released ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of ...

Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial ResultsFourth quarter revenue growth of 19% to $29.5 million2025 revenue growth ...